PT  - JOURNAL ARTICLE
AU  - Buckley, Rita
ED  - Bone, Henry G.
TI  - Transitioning to Denosumab from Continuous Alendronate Therapy Further Improves BMD in Postmenopausal Women with Osteoporosis
DP  - 2011 Sep 01
TA  - MD Conference Express
PG  - 13--14
VI  - 11
IP  - 5
4099  - http://mdc.sagepub.com/content/11/5/13.2.short
4100  - http://mdc.sagepub.com/content/11/5/13.2.full
AB  - This article presents findings on the efficacy and safety of a shift from alendronate (ALN) to denosumab (DMAb) in a subset of women from the 1-year Study of Transitioning from Alendronate to Denosumab [STAND; NCT00377819] trial who transitioned to DMAb after 5 or more years of continuous ALN therapy.